Ebiox secures EPA approvals

Healthcare Enterprise Group PLC ("HCEG" or the Group, AIM: HCEG) is pleased to announce that its wholly owned subsidiary, Ebiox Limited, has secured U.S. Environment Protection Agency ("EPA) approval for its patented concentrate and spray disinfectants.

Trukleen, the registered trade name of the Ebiox surface hygiene products in the U.S., offers significant advantages over other surface cleaners in the U.S. market. By removing biofilm and cleaning to the molecular level, Trukleen is effective against pathogens including viruses, fungi and bacteria such as MRSA. Trukleen is free of damaging chemicals and skin irritants such as alcohols, phenols, chlorine and aldehydes. It is therefore well suited for repeated use on washable surfaces over protracted periods of time.

Applications for individual U.S. state approvals are being submitted immediately and may take up to six months. These approvals will allow HCEG to distribute Trukleen products in a wide range of markets.

Once individual state approvals are secured, HCEG will look to sign further field of use agreements in the healthcare market and exploit additional opportunities within broader markets such as agriculture, food processing and facilities management.

HCEG recently announced a $4.5 million agreement over 5 years with Sultan Healthcare Inc. ("Sultan") for the distribution of Ebiox products in the dental market outside North America. As part of that agreement, the Group will now commence discussions with Sultan to extend its exclusive distribution rights to the dental market within North America with an associated additional financial commitment.

Lyndon Gaborit, HCEG Executive Deputy Chairman commented:

"Regulatory approval in this world market is a major achievement for the Group. The U.S. approval process for these products has taken longer than expected owing to the unique make up of our products. This approval is a further validation of our technology and products."

"Trukleen has huge potential in the U.S. as these non-alcohol surface hygiene products have significant practical advantages whilst being more effective in cleaning and decontaminating."

"With a commitment from Sultan already endorsing Ebiox products in other territories, we are confident that U.S. distribution contracts can be secured".

Enquiries:

Healthcare Enterprise Group +44 (0)20 7351 7500
Lyndon Gaborit, Executive Deputy Chairman

College Hill +44 (0)20 7457 2020
Adrian Duffield/Corinna Dorward

<-- Back